Neurocrine Bioscience buy Morgan Stanley
Start price
31.07.25
/
50%
€112.45
Target price
31.07.26
€138.22
Performance (%)
3.87%
Price
01.10.25
€116.80
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 3.87%. This prediction currently runs until 31.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.509% | -3.509% |
| iShares Core DAX® | 1.631% | -0.020% |
| iShares Nasdaq 100 | 1.073% | 5.074% |
| iShares Nikkei 225® | -0.615% | 5.550% |
| iShares S&P 500 | 1.061% | 3.163% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $150.00 to $158.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€121.85
05.09.25
05.09.25
€139.74
05.09.26
05.09.26
-4.14%
01.10.25
01.10.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
4.67%
01.10.25
01.10.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
11.24%
01.10.25
01.10.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-21.08%
01.10.25
01.10.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25